Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variable coding sequence protein A1 as a marker for erectile dysfunction.

Yuehong Tong1, Moses Tar, Felix Davelman

  • 1Department of Urology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

BJU International
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of diagnostic blood indicators associated with adenomyosis: a retrospective cohort study.

Frontiers in endocrinology·2026
Same author

Subretinal drusenoid deposits are strongly associated with coexistent high-risk vascular diseases.

BMJ open ophthalmology·2026
Same author

Construction of a nomogram model for predicting residual or recurrent cervical intraepithelial neoplasia after the loop electrosurgical excision procedure.

American journal of clinical pathology·2025
Same author

A prognostic model derived from PANoptosis-associated subtypes unveils immunological features and therapeutic vulnerabilities in cervical cancer.

Discover oncology·2025
Same author

Identification of Bacterial Lipopolysaccharide-Related Molecular Subtypes and Development of a Four-Gene Prognostic Risk Model in Cervical Cancer.

International journal of women's health·2025
Same author

Synergy between oral PDE5 inhibitors and topically applied nitric oxide microparticles on the erectile response in a rat model of cavernous nerve injury.

International journal of impotence research·2025
Same journal

Comment on 'Tumour size outperforms nephrometry scores to predict surgical success following partial nephrectomy'.

BJU international·2026
Same journal

STHLM3 NorDCaP: prospective multicentre trial of Stockholm3 for active surveillance biopsy guidance.

BJU international·2026
Same journal

F-URS with FANS versus mPCNL for 2-3 cm UUTS: a RCT with a subgroup analysis of 2-2.5 cm stones.

BJU international·2026
Same journal

Health-related quality of life and patient-reported outcome measures in economic evaluation of urological technologies: challenges and opportunities.

BJU international·2026
Same journal

Comment on 'Artificial intelligence-based approaches to augmenting and automating surgical training'.

BJU international·2026
Same journal

Response to comment on 'Artificial intelligence-based approaches to augmenting and automating surgical training'.

BJU international·2026
See all related articles

Variable coding sequence protein A1 (Vcsa1) is significantly down-regulated in rat models of erectile dysfunction (ED). Restoring Vcsa1 levels in aged rats promoted erectile function, suggesting Vcsa1 as a potential therapeutic target for ED.

Area of Science:

  • Urology
  • Molecular Biology
  • Genetics

Background:

  • Erectile dysfunction (ED) is a common condition with various underlying causes, including diabetes, aging, and nerve damage.
  • The gene variable coding sequence protein A1 (Vcsa1) was identified as significantly downregulated in a rat model of neurogenic ED.
  • Understanding the role of Vcsa1 in erectile function could reveal new therapeutic strategies for ED.

Purpose of the Study:

  • To investigate the expression levels of Vcsa1 in rat models of diabetes, aging, and neurogenic ED.
  • To determine the physiological role of Vcsa1 in erectile function through gene transfer studies.

Main Methods:

  • Quantitative reverse-transcriptase polymerase-chain reaction (RT-PCR) was used to measure Vcsa1 transcript levels in rat corpora cavernosa.

Related Experiment Videos

  • Gene transfer was performed by intracorporal injection of a Vcsa1-expressing plasmid (pVAX-Vcsa1) into aged rats.
  • Erectile function was assessed via intracorporal/blood pressure (ICP/BP) measurements and histological analysis.

    • Main Results:

    • Vcsa1 transcript levels were significantly downregulated (at least 10-fold) in the corpora of all tested rat models of ED.
    • Intracorporal injection of pVAX-Vcsa1 in aged rats led to priapism and increased ICP/BP, indicating enhanced erectile function.
    • Lower doses of pVAX-Vcsa1 also demonstrated a dose-dependent increase in ICP/BP compared to controls.

    Conclusions:

    • Vcsa1 plays a crucial role in regulating erectile function.
    • Downregulation of Vcsa1 is a potential molecular marker for organic ED.
    • Vcsa1 represents a novel therapeutic target for the treatment of erectile dysfunction.